Margaret Moses Branch is an attorney and partner at Branch Law Firm in Albuquerque, New Mexico. She represents clients in medical malpractice, personal injury, mass torts, toxic torts, products liability, and general litigation matters. Admitted to practice in New Mexico and Colorado, she is also admitted to the U.S. Court of Appeals for the Tenth Circuit and the U.S. District Court for the District of New Mexico. Margaret earned her J.D. and B.S. from the University of New Mexico.
LATEST ARTICLES BY: Margaret Moses Branch
FDA Holds Hearings On Transvaginal Mesh
|
|
Last Modified
on
May 02, 2024
The FDA met last week to determine whether surgical mesh inserted surgically inserted into the vagina, also known as transvaginal mesh or pelvic mesh, needs tighter regulation by the FDA. The mesh is used to treat a painful condition called pelvic-organ prolapse. As the result of close to 3000 reports of adverse events, including seven… read more
FDA Warns Of Risks Associated With Transvaginal Mesh
|
|
Last Modified
on
May 02, 2024
Recently the FDA issued a transvaginal mesh warning concerning the use of the medical device (also known as pelvic mesh, pelvic sling, or bladder mesh) as a method to repair pelvic organ prolapse. The FDA warning stated that using transvaginal mesh to repair pelvic organ prolapse exposes patients to an “unnecessary risk” without providing any… read more
DePuy Hip Linked To Metal Poisoning
|
|
Last Modified
on
May 02, 2024
More and more claims concerning the troubled DePuy Hip continue to emerge. A recent article reveals that in addition to extreme pain from the faulty medical device, other symptoms related to metal poisoning occurred. According to one DePuy Hip patient – Tony Stauffer – discussed in the San Diego news, his hair started to fall… read more
DePuy Hip Recall Makes Some Experts Question FDA Medical Device Review Process
|
|
Last Modified
on
May 02, 2024
A recently released medical device study concludes that the FDA should “abandon” its present system for approving U.S. medical devices such as the DePuy Hip because it fails to ensure patient safety. Currently, the FDA employs a streamlined approach to approve medical device applications such as those for the beleaguered DePuy knee and hip parts… read more
Yaz Investigated For Increased Risk Of Blood Clots
|
|
Last Modified
on
Mar 16, 2024
Many types of birth control pills create risks of blood clots. However, new birth control research suggests that certain types of pills create an even higher risk of blood clots than others. Birth control pills that contain Drospirenone – such as Yaz, Yasmin, and Beyaz contain a two to three-time higher risk for developing blot… read more
Zimmer Introduces New Tool For Use In Defective Knee Revision Surgeries
|
|
Last Modified
on
May 02, 2024
Zimmer Holdings – maker of the defective Zimmer NexGen knee replacements – has recently announced that it has developed a complete set of Trabecular Metal material augmented shapes and cones to be used in knee revision surgeries. These new augments are intended to fill any size bone defects detected while performing surgery and supposed to… read more
Topamax May Alter Effectiveness Of Birth Control Pills
|
|
Last Modified
on
Mar 16, 2024
Recent reports indicate that in addition to problems such as cleft palates and cleft lip from taking Topamax, Topamax may cause oral contraceptives to lose their effectiveness. Topamax (topiramate) is a popular migraine and seizure medication that has been recently revised by the FDA as a “Class D” pregnancy drug – i.e. one where significant… read more
Topamax Recall After Reports Of Unusual Odors
|
|
Last Modified
on
Mar 16, 2024
Johnson & Johnson has issued a Topamax recall after receiving complaints about an unusual odor linked to a byproduct from a chemical used in treating wood. Sources believe the contamination may have occurred as a result of the way medication is shipped and stored. Topamax has recently come under fire after the FDA issued warnings… read more
Senate To Begin Investigation Of DePuy Hip Safety
|
|
Last Modified
on
May 02, 2024
This week the U.S Senate will begin its probe into medical device recalls and the connection between the massive DePuy Hip Replacement recall and the FDA’s role in “protecting patient safety as part of the medical device approval process.” The DePuy Hip was recalled after numerous reports of metal shards breaking off the hip replacement… read more
Zimmer NexGen Knee Recall Urged Due To Component Problems
|
|
Last Modified
on
May 02, 2024
Several physicians are urging a Zimmer NexGen Knee recall as the result of serious problems and component failures in the knee, requiring additional surgeries. The FDA has recalled some of the components following several lawsuits concerning the Zimmer NexGen CR-Flex knee failure rate. In fact, a prominent consultant for Zimmer recently went public stating that… read more
